India to invest in infrastructure that drugmakers can share

India intends to establish 10 drug manufacturing clusters in the country and invest in infrastructure there like water, power and sewer treatment facilities that drugmakers can share in an effort to cut costs. Ananth Kumar, minister of Chemicals and Fertilisers, told the Economic Times that the intent was to help the industry become more globally competitive and in turn make healthcare in India more affordable. It is expected the clusters would allow drugmakers to reduce expenses by 25%. The country is preparing to invest about $27.3 million in the infrastructure projects. Story | More from FiercePharmaAsia

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.